Investigating the consistency of extracellular vesicle production from breast cancer subtypes using CELLine adherent bioreactors

Citations Over TimeTop 15% of 2022 papers

Abstract

Extracellular vesicle (EV) research has grown rapidly in recent years, largely due to the potential use of EVs as liquid biopsy biomarkers or therapeutics. However, in-depth characterisation and validation of EVs produced using conventional in vitro cultures can be challenging due to the large area of cell monolayers and volumes of culture media required. To overcome this obstacle, multiple bioreactor designs have been tested for EV production with varying success, but the consistency of EVs produced over time in these systems has not been reported previously. In this study, we demonstrate that several breast cancer cell lines of different subtypes can be cultured simultaneously in space, resource, and time efficient manner using CELLine AD 1000 systems, allowing the consistent production of vast amounts of EVs for downstream experimentation. We report an improved workflow used for inoculating, maintaining, and monitoring the bioreactors, their EV production, and the characterisation of the EVs produced. Lastly, our proteomic analyses of the EVs produced throughout the lifetime of the bioreactors show that core EV-associated proteins are relatively consistent, with few minor variations over time, but that tracking the production of EVs is a convenient method to indirectly monitor the bioreactor and consistency of the yielded EVs. These findings will aid future studies requiring the simultaneous production of large amounts of EVs from several cell lines of different subtypes of a disease and other EV biomanufacturing applications.

Related Papers

• → Living With Heterogeneities in Bioreactors: Understanding the Effects of Environmental Gradients on Cells(2006)384 cited
• → Stirred Bioreactors(2016)23 cited
• → Bioreactor for biopharmaceutical production: Simple controlled environment design(2018)1 cited
• → Scale-Up Production of Bioactive Compounds Using Bioreactors(2022)1 cited
• → [RETRACTED] Methods for HIV Promotes Atherosclerosis via Circulating Extracellular Vesicle microRNAs v1(2021)